Capturing What Matters: Patient Reported LGI1-ANTibody Encephalitis Outcome RatiNg Scale (LANTERN) (P9-8.006)
To develop a disease-specific, patient-reported outcome measure (PROM) for LGI1-antibody-encephalitis (LGI1-Ab-E), to be used in clinical and research practice.
Authors
- Bryan Ceronie (ORCID: https://orcid.org/0000-0001-7944-9924)
- Ann Lin (ORCID: https://orcid.org/0000-0002-4618-8120)
- Adam E. Handel (ORCID: https://orcid.org/0000-0001-8385-6346)
- Mark Kelly (ORCID: https://orcid.org/0000-0001-7214-5039)
- Sarosh R. Irani (ORCID: https://orcid.org/0000-0002-7667-9748)
- John Soltys
- Sophie Binks (ORCID: https://orcid.org/0000-0003-0991-5998)
- Christine Strippel (ORCID: https://orcid.org/0000-0002-7080-6769)
- Philip A. Powell (ORCID: https://orcid.org/0000-0003-1169-3431)
- Barbara Wagner (ORCID: https://orcid.org/0000-0002-5398-6438)
Institutions
- Royal College of Surgeons in Ireland (IE)
- WinnMed (US)
- University of Oxford (GB)
- Kantonsspital Aarau (CH)
- University of Sheffield (GB)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000210640
- Primary Topic
- Autoimmune Neurological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00